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In considering the acute, short-term, or long-term treat-
ment of schizophrenia, treatment goals and health con-
siderations vary according to the phase of schizophrenia.
Related to this are concerns about metabolic abnormali-
ties associated with the use of atypical antipsychotics. The
atypical antipsychotics vary in their effects on cardiovas-
cular risk factors, weight, and insulin sensitivity, a consid-
eration that needs to be included in psychiatrists' patient
education and treatment decisions. Insulin resistance and
abdominal adiposity are directly related, and insulin
resistance has multiple deleterious effects throughout the
body. Many of the typical and atypical antipsychotics can
promote weight gain. Both aripiprazole and ziprasidone
cause about 0.5 kg weight increase over the course of a
year, while amisulpride and risperidone can promote a 2
kg weight gain per one year. Recent data show that
quetiapine is associated with a 3.5 kg weight gain over one
year. Clinical trial evidence suggests that olanzapine car-
ries the greatest risk of weight gain, with nearly 14 kg of
weight gain over one year. On the basis of the evidence
that psychiatric patients receiving antipsychotics are at
least as sensitive as the general population to the effects of
obesity, clinicians need to strongly consider the effects of
antipsychotics on weight gain as they make clinical deci-
sions.
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